echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > World Acromegaly Day: ASO drugs show efficacy

    World Acromegaly Day: ASO drugs show efficacy

    • Last Update: 2021-12-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    news

    news

    Today ASO manufacturer Ionis announced a phase II clinical result of acromegaly of its liver-targeted growth hormone receptor (GHR) trans-nucleic acid drug Cemdelirsen (IONIS-GHR-L)


    Drug source analysis

    Drug source analysis

    Today is World Acromegaly Day.


    Cemdelirsen is a GalNac-coupled ASO, so it only has a significant effect on liver GHR


    ASO is a treatment with a longer history than RNAi and mRNA, but because the delivery problem has not been solved, progress has been slow in the first two decades


    The discovery of GalNac completely changed the fate of RNA drugs, but also restricted the target to the liver.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.